ABSTRACT. The purpose of the present study was to determine the prevalence of antibiotic-resistant enterococci in dogs and cats subjected to differing antibiotic pressures, and the prevalence of vancomycin resistance genes in isolates from these animals. Enterococci were isolated from fecal samples of 65 healthy dogs and 29 healthy cats brought to animal hospitals, from rectal swabs of 73 puppies and 15 kittens from five breeders and two pet shops, and from fecal samples of 20 dogs and 9 cats that were treated with antibiotics in Nippon Veterinary and Life Science University Animal Medical Center. The rates of resistance to ampicillin among isolates from the kitten-puppy group and healthy dog-cat group were 6.8 and 4.3%, respectively. In contrast, the rates of resistance to ampicillin in enterococci from the treatment group under antibiotic pressure were 37.5%. There was a significant difference between the antibiotic-treated group and the untreated group (P<0.01). Similarly, in the treatment group, the rate of resistance to enrofloxacin was extremely high (75.0%). In comparison, in the healthy group and kitten-puppy group, the rates of resistance to enrofloxacin were 23.4 and 12.1%, respectively. Among these groups, a significant difference was also observed in the apparent resistance rates (P<0.01). Vancomycin-resistant enterococci (VRE) harboring vanA or vanB were not detected in any groups. Therefore, contamination of VRE in dogs and cats is still considered to be minimal in Japan.
Enterococci are normal microbial flora of the gastrointestinal tract of humans and animals, and the major species of enterococci are Enterococcus faecalis, E. faecium and E. durans [1, 2, [13] [14] [15] . Generally speaking, enterococci are weak pathogens that do not cause illness in healthy humans or animals. However, enterococci have emerged as an important cause of nosocomical infections and have been found to quickly acquire resistance to many antimicrobials [6, 21] .
In recent years, the appearance of vancomycin-resistant enterococci (VRE) has caused serious problems both in humans and in veterinary medicine [11, 24] . Resistance to glycopeptides in enterococci is mediated by vanA, vanB and vanC cluster, and the vanA genotype is considered to be of major importance [3] . The vanA genotype is the predominant resistant genotype and is characterized by acquired inducible resistance to both vancomycin and teicoplanin. The vanB cluster confers inducible resistance to various levels of vancomycin, and isolates exhibit susceptibility to teicoplanin, because this antibiotic is not an inducer. The vanC-type glycopeptide resistance is characterized by chromosomallyencoded and constitutively expressed resistance to low levels of vancomycin, but susceptibility to teicoplanin. This resistance has been described as an intrinsic property of E. gallinarum, E. casseliflavus and E. flavescens [3] .
Vancomycin-resistat E. faecium strains carrying the vanA gene have been isolated from chicken, pigs and cattle, as well as meat from these animals [7, 9, 17] . Some epidemiological studies suggest that animals carrying VRE in their gastrointestinal tract could be the source of VRE infections in humans [31] . These VRE of animal origin can colonize humans, being able then to transfer their resistance genes to other human intestinal bacteria [4, 28] . There are no reports about the propagation of VRE in companion animals to humans. However, there are reports that Staphylococcus aureus and Campylobacter jejuni were propagated from companion animals to humans [29, 32] .
In Japan, companion animals are being increasingly reared indoors [30] , and as a result, pet owners have more opportunities for contact with companion animals. Potential transmission of pathogenic and/or antimicrobial resistant bacteria from companion animals to their keepers have been reported frequently [5, 23] . Therefore, monitoring of drugresistant bacteria and pathogenic bacteria in companion animals has become important in public health and the veterinary medicine. However, only a few studies have reported VRE in companion animals in Japan and overseas [12, 16, 26] .
In this study, we aimed to collect basic data derived from epidemiological survey of enterococci in dogs and cats as companion animals bred in Japan. In addition, we examined the relationship between antimicrobial susceptibility of enterococci and the selective pressure of antibiotics in these animals. in Saitama) and two pet shops (30 puppies and 7 kittens; 1 shops in Tokyo and 1 in Kanagawa). There was no history of antimicrobial exposure in the puppies and kittens, but it is possible that the dams were administered lincomycin for postpartum infection prophylaxis.
Isolation and identification of enterococci: All samples were plated onto EF agar (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) plates and Enterococcosel agar (Becton, Dickinson and Co., Tokyo, Japan) plates and incubated aerobically at 37°C for 48 hr. From each plate, one or more colonies with morphological characteristic of enterococci (i.e., dark brown halo) were initially tested by Gram staining, growth in 6.5% NaCl broth and bile esculin hydrolysis. All presumed enterococci were further identified as described by Facklam and Collins [10] . In group 1, because the number of hospitals varied with region, the following tests were used to one strain/head randomly selected in consideration of a regional difference. In the other two groups, multiple strains/ head were also tested in the following experiments. Those strains were selected based on differences in the size of halo and morphology of colonies. Enterococcal isolates were stored at −80°C until used for testing. [6, 8, 27] . After incubation in trypticase soy broth (Becton, Dickinson and Co.) overnight at 37°C, a 25µl of culture volume was mixed with 25 µl of InstaGene Matrix kit (Bio-Rad Laboratories, Hercules, CA, U.S.A.). Cell suspensions were heated for 10 min at 100°C and centrifuged. A volume (2.5 µl) of the supernatant was then used for PCR amplification. The four primer sets shown in Table 1 were added to the reaction mixtures as follows: 5 pmol of the vanA primers; 2.5 pmol each of the vanB, vanC1 and vanC2/ C3 primers. A multiplex PCR assay was performed in a total volume of 25 µl containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 0.2 mM of each deoxynucleotide triphosphate (dATP, dCTP, dGTP and dTTP) and 0.625 U of Taq DNA polymerase (Takara Bio Inc., Otsu, Japan). A TaKaRa PCR Thermal Cycler Dice ® mini thermocycler was used and programmed as follows: initial denaturation at 94°C for 5 min, 30 cycles of amplification (denaturation at 94°C for 1 min, annealing at 54°C for 1 min and extension at 72°C for 1 min) and a final extension at 72°C for 10 min. PCR products were analyzed by the agarose gel electrophoresis. Enterococcus faecium ATCC 51559 (vanA-containing reference strain), E. faecalis ATCC 51299 (vanB), E. gallinarum ATCC 49573 (vanC1) and E. casseliflavus ATCC 25788 (vanC2/3) were used as VRE controls.
Statistical analysis: The statistical software Stat View ver5.0 was used for all analyses. Categorical variables were analyzed by univariate analysis using the Chi-square method or Fisher's exact test. Differences were considered significant when the P value was less than 0.05. Table 2 shows the results of identification of Enterococcus species in each group. In group 1 dogs, the most prevalent enterococcal species was E. faecalis (52.3%); E. faecium and E. durans were isolated from 27.7% (18 of 65) and 13.8% (9 of 65) of subjects, respectively. Similarly, the microbe most frequently isolated from healthy cats was E. faecalis (48.3%), followed by E. faecium (37.9%) and E. durans (10.3%). In group 2 dogs, the most prevalent species was E. faecium, which accounted for 60.4% of subjects. In group 2 cats, E. faecium was also most prevalent (61.1%). These adult dogs and cats were mainly held by E. faecalis and E. faecium. In contrast, in puppies that had not been exposed to antibiotics, E. faecalis was the most prevalent (66.4%) enterococcal species. In kittens, E. hirae was the most prevalent species, present in 40.0% of subjects.
RESULTS

Identification of enterococci:
Antimicrobial susceptibility tests: Results of drug susceptibility tests are shown in Table 3 . No significant differences were observed among the three groups in the rates of resistance of enterococci to DSM, GM, KM, EM or CP. However, rates of resistance to ABPC in group 1 and group 3 were 4.3 and 6.8%, respectively. In contrast, the rate of resistance to ABPC in the enterococci from group 2 was as high as 37.5%. There was a significant difference between the two groups that were not under antibiotic pressure and the group that had been exposed to antibiotics (P<0.01). Similarly, in group 2, the rate of resistance to ERFX was 75.0%. In contrast, in the other two groups, the rates of resistance to ERFX were 23.4 and 12.1%, respectively. Among these groups, a significant difference was also observed in the apparent resistance rates (P<0.01). Differences of resistant rates between any groups were not related to differences of enterococcal species.
Detection of vancomycin resistance genes: Results of the detection of vancomycin resistance genes by multiplex PCR are shown in Table 2 . VanA and vanB, which indicate high-level resistance to vancomycin, were not detected in any of the groups. In group 1, three strains of E. gallinarum carried vanC1 and one strain of E. casseliflavus possessed the vanC2/3. In group 3, two strains of E. gallinarum was also detected vanC1. A similar result was obtained in group 2: one strain of E. gallinarum carried vanC1. There was no significant difference in the presence of van genes among the three groups.
DISCUSSION
In this study, we clarified the differences observed in the antibiotic-resistance rates of enterococci in dogs and cats under various antibiotic selective pressures. Among three groups tested, significant differences were observed in the rates of resistance to ABPC and ERFX. Specifically, in dogs and cats under antibiotic selective pressure, the rates of resistance to these drugs were 37.5 and 75.0%, respectively. In contrast, in groups under little or no antibiotic selective pressure, rates of resistance to these antibiotics were lower than that in a group under antibiotic selective pressure. These results suggest that the history of ABPC (penicilins; 14/29) and ERFX (quinolones; 19/29) use had a significant impact on resistance rates. In our past survey, cephalexin, ERFX, amoxicillin and ABPC were used in more than 75 percent of animal hospitals in Japan [18] , implying that high rates of resistance are most likely due to the frequent use of ABPC and ERFX as antimicrobials in veterinary medicine.
In group 3, which had not been exposed to antibiotics, resistance to certain antimicrobial agents was confirmed, and we speculate that resistance to enterococci may have been propagated from parental animals. In support of this notion, Staphylococcus aureus on parental skin readily establishes in the infantile gut [22] . In this way, normal flora is easily transmitted from parental animals to kittens or puppies, perhaps due to poor competition from other gut bacteria. In our study, we note that the resistance rates of enterococci in the kitten-puppy group were similar to that of the healthy group.
Rodrigues et al. have reported that pets are important reservoirs of drug-resistant enterococci in Portugal [26] , detecting resistance to ABPC in 21.2%, to EM in 100% and to ERFX in 76.9% of strains, respectively. Furthermore, Jackson et al. reported that ciprofloxacin-, CP-and GM-resistant enterococci were isolated from 90, 85 and 79%, of dogs and cats in the United State, respectively [16] . These results are similar to the resistance rates of the antibiotic pressure group in our study. This may be probably derived from the same antibiotics used to treat dogs and cats in other countries and Japan.
In this study, VRE harboring vanA or vanB in any of the groups was not detected. In contrast, Herrero et al. reported that 15 VRE strains, all resistant to vancomycin and harboring vanA, were obtained from 12.6% of dogs at the Animal Hospital of the School of Veterinary Medicine in Madrid, Spain [12] . Based on these results, contamination of VRE in dogs and cats is considered to be minimal in Japan. As shown in the report of Kuhn et al. [20] , Spain has a particularly high rate of VRE contamination among European countries: contamination has been estimated at 36% in humans, and at 30% in pigs. In contrast, only 5% of humans are contaminated in Japan [25] , whereas contamination in food-producing animals has not been detected [19] . Collectively, these results indicate that VRE was not isolated from fecal samples of dogs and cats in Japan without horizontal transfer of van genes from human and livestock and without environmental pollution of van genes. However, in Spain, highly resistant VRE colonization has been observed in dogs and cats. If antimicrobial agents used in foreign countries are approved and gain use in Japan, there is a possibility the carrier rate of VRE in companion animals may increase in the future. Therefore, it will be necessary to monitor the presence of drug-resistant bacteria including VREs in companion animals.
In conclusion, given that overuse of antibiotics in clinical small animal medicine can cause the spread of resistance genes and resistant enterococci, we suggested that antibiotics should be used more appropriately by each veterinarian.
